Bayer Shares Sag After US Jury Verdict in Roundup Cancer Trial

Edwin Hardeman (R), with his attorneys Jennifer Moore (L) and Aimee Wagstaff, speaks to the media, after Bayer AG was found liable for Hardeman’s non-Hodgkin’s lymphoma arising from his use of the company’s weed killer Roundup, at the Federal court in San Francisco, California, U.S., March 27, 2019. REUTERS/Alexandria Sage

FRANKFURT—Bayer AG shares sank to their lowest in almost seven years on March 28 after a U.S. jury awarded $80 million to a man who claimed use of the group’s weed killer Roundup caused his cancer, with thousands of similar lawsuits looming.

The jury in San Francisco federal court on March 27 found Bayer liable because its Monsanto unit did not warn plaintiff Edwin Hardeman of the herbicide’s alleged cancer risks.